Optical Coherence Tomography (OCT) for Ophthalmology

Optical Coherence Tomography (OCT) for Ophthalmology

Global Optical Coherence Tomography (OCT) for Ophthalmology Market to Reach US$1.1 Billion by 2030

The global market for Optical Coherence Tomography (OCT) for Ophthalmology estimated at US$684.3 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$908.4 Million by the end of the analysis period. Growth in the Handheld & Integrated OCT Systems segment is estimated at 9.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$187.6 Million While China is Forecast to Grow at 10.0% CAGR

The Optical Coherence Tomography (OCT) for Ophthalmology market in the U.S. is estimated at US$187.6 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$141.6 Million by the year 2030 trailing a CAGR of 10.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.0% CAGR.

Global Optical Coherence Tomography (OCT) for Ophthalmology Market - Key Trends and Drivers Summarized

Optical Coherence Tomography (OCT) is a non-invasive imaging test that uses light waves to take cross-section pictures of the retina. With OCT, each of the retina`s distinctive layers can be seen, allowing ophthalmologists to map and measure their thickness. These measurements help with the detection of retinal diseases and conditions such as age-related macular degeneration, diabetic eye disease, and glaucoma. OCT is pivotal in ophthalmology not only for diagnostic purposes but also for the monitoring of treatment progress and pre-surgical planning. The technology provides high-resolution images, making it an indispensable tool in clinical practices for assessing and treating retinal diseases.

The application of OCT in ophthalmology has dramatically transformed the field, particularly in the management of retinal diseases and surgical planning. It allows for early detection of structural changes in the retina, which can be critical for preventing irreversible damage and blindness. The versatility of OCT extends beyond diagnosis; it is also used in tracking the disease`s progression and the effectiveness of ongoing treatments. Moreover, as the technology has evolved, newer generations of OCT machines have incorporated advanced features such as angiography without the need for dye injection, allowing for detailed visualization of blood flow in the retina. This capability is particularly useful for managing vascular conditions of the eye, such as diabetic retinopathy and vascular occlusions, which are among the leading causes of vision impairment and blindness.

The growth in the Optical Coherence Tomography market for ophthalmology is driven by several factors, including technological advancements, an aging global population, and an increasing prevalence of retinal diseases. Technological innovations have led to the development of more sophisticated OCT systems that offer higher resolution, deeper penetration, and faster scanning times, significantly enhancing diagnostic accuracy and patient throughput in clinical settings. The aging demographic, particularly in developed countries, presents a growing patient base for age-related ocular conditions that require OCT for diagnosis and management. Furthermore, the rise in systemic diseases such as diabetes has increased the incidence of associated eye conditions, thereby boosting the demand for OCT imaging. Consumer behavior has also shifted towards preventive healthcare measures, leading to earlier screenings and treatments, which utilize OCT imaging extensively. These factors collectively contribute to the robust growth of the OCT market in ophthalmology, reflecting its increasing importance in eye care and disease management.

Select Competitors (Total 26 Featured) -

• Carl Zeiss Meditec AG
• NIDEK Co., Ltd.
• BaySpec, Inc.
• Heidelberg Engineering GmbH
• Haag-Streit AG
• Huvitz Co., Ltd.
• NinePoint Medical
• Optos PLC
• Optovue, Inc.
• Rowiak GmbH
• Novacam Technologies, Inc.
• DELBio, Inc.
• Cylite
• Chongqing Vision Star Optical Co., Ltd.
• Industrial Technology Research Institute (ITRI)

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.